GlassScriptPhysician profile
Swati Chopra
NPI 1275078818
$3,003.63
in general payments reported to CMS, 2019-2025
28 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.00 · 2021: $86.40 · 2022: $444 · 2023: $1,047 · 2024: $830 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,428 · Long Term Medical Supply Or Device Loan: $29.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.46 |
| Long Term Medical Supply Or Device Loan | $29.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $560.12 | 2022-2025 | Mounjaro, Jardiance, Humulin |
| Medtronic, INC. | $325.92 | 2023-2024 | Minimed 780g |
| Insulet Corporation | $219.87 | 2023-2025 | Omnipod |
| Corcept Therapeutics | $194.72 | 2023-2025 | Korlym |
| Cequr Corporation | $189.71 | 2023-2025 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $186.42 | 2022-2025 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $179.83 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $162.40 | 2020-2024 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.92 | 2022-2025 | Jardiance |
| Dexcom, INC. | $97.06 | 2021-2023 | Dexcom G6 Transmitter |
| Radius Health, INC. | $88.58 | 2024 | Tymlos |
| Abbott Laboratories | $87.78 | 2022-2024 | Freestyle Insulinx, Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $72.86 | 2023-2025 | |
| Corium, LLC | $71.24 | 2021-2022 | |
| Exact Sciences Corporation | $69.19 | 2023-2025 | Cologuard Collection Kit |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $67.83 | 2023 | Tepezza |
| Sequel Med Tech, LLC | $38.76 | 2025 | Twiist |
| Pfizer INC. | $34.11 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $32.66 | 2021-2022 | |
| Amgen INC. | $30.87 | 2025 | Evenity, Prolia |
| Amneal Pharmaceuticals LLC | $26.08 | 2023 | Unithroid |
| Takeda Pharmaceuticals U.S.A., INC. | $22.79 | 2022 | |
| Neos Therapeutics, LP | $21.21 | 2022 | |
| Ironshore Pharmaceuticals INC. | $19.57 | 2023 | Jornay Pm |
| Bayer Healthcare Pharmaceuticals INC. | $18.89 | 2024 | |
| Beta Bionics, INC. | $14.84 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Recordati_rare_diseases_inc. | $13.92 | 2022 | |
| Merck Sharp & Dohme LLC | $13.48 | 2023 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swati Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.